Trial Profile
A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2010
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Trichotillomania
- Focus Therapeutic Use
- 20 Apr 2010 Results were published early online in the Journal of Clinical Psychiatry.
- 27 Nov 2005 New trial record.